Ligne de temps
17 sept. 2022
publication
In Silico Conformational Features of Botulinum Toxins A1 and E1 According to Intraluminal Acidification.
Lire plus01 mai 2021
publication
Characterization of a highly neutralizing single monoclonal antibody to botulinum neurotoxin type A.
Lire plus12 sept. 2019
publication
Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches
Lire plus23 juil. 2019
13 sept. 2018
02 oct. 2017
publication
The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies
Lire plus12 sept. 2016
25 août 2016
publication
Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B
Lire plus06 oct. 2015
17 sept. 2015
publication
Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A1 and A2 by targeting their heavy chain
Lire plus09 janv. 2014
publication
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library
Lire plus20 sept. 2013
publication
Synthetic self-assembling clostridial chimera for modulation of sensory functions
Lire plus13 avr. 2011
publication
Phrenic nerve-hemidiaphragm as a highly sensitive replacement assay for determination of functional botulinum toxin antibodies
Lire plus01 avr. 2009
publication
Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve-hemidiaphragm: improved precision with in-bred mice
Lire plus13 mai 2005
01 sept. 1996
01 juin 1996
publication
Effects of tumor necrosis factor and interleukin-1 on the constriction induced by angiotensin II in rat aorta
Lire plus01 déc. 1995
publication